| Literature DB >> 34232183 |
Hongjian Ji1,2,3, Jingyin Hu4, Guozhe Zhang5, Jianxiang Song3, Xiaohua Zhou3, Dean Guo1,2.
Abstract
BACKGROUND: Aristolochic acid nephropathy (AAN) is a type of drug-induced nephropathy that may result in acute kidney injury and is associated with a potentially progressive course of kidney fibrosis and upper tract urothelial carcinoma. Aristolochic acids (AAs) are a group of toxins commonly present in plants of the genera Aristolochia and Asarum, which are found worldwide. AAN still occurs in Asian and Balkan regions. The progressive lesions and mutational events initiated by AAs are irreversible, and no effective therapeutic regimen for AAN has been established. Furthermore, more people are at risk of this disease due to casual exposure to AAs. This study performed a scientometric analysis of global research literature focusing on AAN.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34232183 PMCID: PMC8270620 DOI: 10.1097/MD.0000000000026510
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Top 10 most productive journals.
| Rank | Journal | N (%) | Impact factor | H-index | Average citations per item |
| 1 | Kidney International | 44 (4.1%) | 8.945 | 23 | 46.14 |
| 2 | Food and Chemical Toxicology | 30 (2.8%) | 4.531 | 18 | 31.77 |
| 3 | Toxins | 24 (2.2%) | 4.679 | 14 | 44.96 |
| 4 | Nephrology Dialysis Transplantation | 23 (2.1%) | 3.531 | 16 | 31.91 |
| 5 | Renal Failure | 21 (1.9%) | 2.089 | 9 | 9.05 |
| 6 | Archives of Toxicology | 19 (1.8%) | 1.985 | 15 | 45.74 |
| 7 | Toxicology | 17 (1.6%) | 5.059 | 15 | 43.35 |
| 8 | PLOS One | 16 (1.5%) | 2.740 | 10 | 21.13 |
| 9 | American Journal of Kidney Diseases | 14 (1.3%) | 4.099 | 13 | 85.43 |
| 10 | Chemical Research in Toxicology | 14 (1.3%) | 6.618 | 9 | 32.86 |
The top 20 recurring terms from keywords.
| Keyword | Occurrence (% of 1083 publications) |
| Balkan endemic nephropathy | 410 (37.9%) |
| Aristolochic acid | 310 (28.6%) |
| Chinese herbs nephropathy | 203 (18.7%) |
| Nephropathy | 194 (17.9%) |
| Ochratoxin A | 172 (15.9%) |
| Aristolochic acid nephropathy | 131 (12.1%) |
| Toxicity | 110 (10.1%) |
| DNAadducts | 96 (8.9%) |
| Kidney | 95 (8.8%) |
| Nephrotoxicity | 88 (8.1%) |
| Rats | 86 (7.9%) |
| Etiology | 85 (7.8%) |
| Chinese herbs | 81 (7.5%) |
| Cancer | 80 (7.4%) |
| Urothelial carcinoma | 77 (7.1%) |
| Exposure | 75 (6.9%) |
| Apoptosis | 73 (6.7%) |
| Urothelial cancer | 70 (6.4%) |
| DNA adduct formation | 60 (5.5%) |
| Reductive activation | 57 (5.3%) |
Figure 1The number of publications on aristolochic acid nephropathy (AAN) every year.
Figure 2Top 10 most productive countries.
Top 10 publications selected by citations.
| Rank | Authors | PubMed ID | Country | Year | Journal | Cited by |
| 1 | Jha et al[ | 23727169 | India | 2013 | Lancet | 1687 |
| 2 | Vanherweghem et al[ | 8094166 | Belgium | 1993 | Lancet | 756 |
| 3 | Nortier et al[ | 10841870 | Belgium | 2000 | New England Journal of Medicine | 683 |
| 4 | Pfohl-Leszkowicz et al[ | 17195275 | France | 2007 | Molecular Nutrition & Food Research | 628 |
| 5 | Peraica et al[ | 10534900 | Croatia | 1999 | Bulletin of the World Health Organization | 439 |
| 6 | Debelle et al[ | 18418355 | Belgium | 2008 | Kidney International | 416 |
| 7 | Grollman et al[ | 17620607 | USA | 2007 | Proceedings of the National Academy of Sciences of the United States of America | 389 |
| 8 | Arlt et al[ | 12110620 | England | 2002 | Mutagenesis | 327 |
| 9 | Marquardt et al[ | 1474034 | Canada | 1992 | Journal of Animal Science | 319 |
| 10 | Finkelman et al[ | Not reported | USA | 2002 | International Journal of Coal Geology | 284 |
Figure 3Bubble map visualizing words from keywords of the 1083 aristolochic acid nephropathy publications. Only words that appeared in at least 1.0% of the publications were analyzed and visualized.